Cognitive Behavioral Therapy-Email (iCBT-E) for Specific Phobias

"This medical trial seeks 256 individuals diagnosed with autism spectrum disorder, ranging in age from 7 to 15 years old. To be eligible, they must satisfy the following requirements: have an IQ of over 70 on both their full scale and verbal comprehension tests; verbally communicate fluently; reside in Texas while partaking in calls regarding the study; possess a primary presenting problem of either anxiety or Obsessive Compulsive Disorder (OCD); and have at least one adult guardian that is available and willing to participate."

"Affirmative. On clinicaltrials.gov, there is information that suggests this medical trial has openings for 256 patients from a single site and was first launched on March 28th 2022 with the latest update being September 13th 2022."

"This trial is suitable for patients aged between 7 to 15. Clinicialtrials.gov currently lists 494 trials available to people under 18 and 899 open clinical studies suitable for participants over 65."

"This trial, which was first made available on March 28th 2022 is still actively seeking out new participants as per clinicaltrials.gov's records that were most recently updated in September 13th of the same year."

"This trial, spanning seven days in total, will assess the 5-item Pediatric Anxiety Rating Scale - Autism Spectrum Disorder. Secondary objectives involve incorporating the Revised Child Anxiety and Depression Scale- Self-Report- Anxious Subscale which is graded from 0 ("never") to 3 ("always"), yielding a score between 0 and 111; Social Responsiveness Scale, Second Edition scored on a 1 ("not true") to 4 ("almost always true") range (higher scores indicate greater impairment), totalling raw points of 65 to 260; as well as Sheehan Disability Scale with each item evaluated on a 0 ("not at all") to 10(""